Sichuan Kelun-Biotech Biopharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,130	1,529	92.96	81.79
Short-Term Investments	383.33	325.87	-	-
Trading Asset Securities	371.54	633.71	-	-
Cash & Short-Term Investments	2,885	2,488	92.96	81.79
Cash Growth	81.56%	2576.80%	13.65%	-
Accounts Receivable	24.25	1.35	61.8	22.73
Other Receivables	139.17	123.1	42.63	47.83
Receivables	163.41	124.45	104.43	70.56
Inventory	60.91	63.03	52.64	50.72
Prepaid Expenses	0.54	35.65	-	-
Other Current Assets	47.9	96.01	82.29	95.27
Total Current Assets	3,158	2,807	332.32	298.34
Property, Plant & Equipment	663.82	692.73	647.82	474.17
Other Intangible Assets	2.45	1.34	3.18	0.49
Other Long-Term Assets	10.49	8.2	9.83	39.97
Total Assets	3,835	3,510	993.15	812.96
Accounts Payable	423.52	404.38	327.46	325.28
Accrued Expenses	88.01	133.77	86.61	44.72
Short-Term Debt	-	-	2,891	2,388
Current Portion of Leases	34.35	54.41	82.26	1.66
Current Income Taxes Payable	3.71	3.73	2.7	2.52
Current Unearned Revenue	2.69	510.69	163.98	109.04
Other Current Liabilities	1.49	3.03	613.57	573.72
Total Current Liabilities	553.77	1,110	4,167	3,445
Long-Term Leases	3.89	5.51	41.29	1.25
Long-Term Unearned Revenue	67.85	64.74	10.68	10.68
Total Liabilities	625.51	1,180	4,219	3,457
Common Stock	222.85	219.2	107.37	107.37
Retained Earnings	-3,746	-4,056	-3,482	-2,866
Comprehensive Income & Other	6,732	6,167	148.63	114.83
Shareholders' Equity	3,209	2,329	-3,226	-2,644
Total Liabilities & Equity	3,835	3,510	993.15	812.96
Total Debt	38.24	59.92	3,014	2,391
Net Cash (Debt)	2,847	2,428	-2,921	-2,309
Net Cash Per Share	13.09	13.22	-30.58	-24.98
Filing Date Shares Outstanding	222.84	219.2	215.83	92.46
Total Common Shares Outstanding	222.84	219.2	107.37	92.46
Working Capital	2,604	1,697	-3,835	-3,147
Book Value Per Share	14.40	10.63	-30.05	-28.60
Tangible Book Value	3,207	2,328	-3,229	-2,644
Tangible Book Value Per Share	14.39	10.62	-30.08	-28.60
Buildings	-	294.4	-	-
Machinery	-	262.26	221.56	200.16
Construction In Progress	-	119.99	348.59	282.36
Leasehold Improvements	-	14.45	13.67	0.38

Source: S&P Capital IQ. Standard template. Financial Sources.